Drugs in myocardial infarction

Margherita Tozzi; Martina Di Piazza; Paolo Meani

doi:10.1007/978-3-030-71917-3_13

Drugs in myocardial infarction

Margherita Tozzi
, Martina Di Piazza
, Paolo Meani^*

^*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic

Abstract

According to the "Fourth universal definition of myocardial infarction," Acute Myocardial Infarction (AMI) is a "myocardial injury detected by abnormal cardiac biomarkers with clinical evidence of acute myocardial ischemia" [1]. The criteria include abnormal cardiac troponin (cTn) values with at least one value above the 99th percentile upper reference limit (URL), and at least one of the following:

Original language	English
Title of host publication	Reducing Mortality in Critically Ill Patients
Editors	Giovanni Landoni, Martina Baiardo Redaelli, Chiara Sartini, Alberto Zangrillo, Rinaldo Bellomo
Publisher	Springer International Publishing
Pages	115-124
Number of pages	10
Edition	2
ISBN (Electronic)	9783030719173
ISBN (Print)	9783030719166
DOIs	https://doi.org/10.1007/978-3-030-71917-3_13
Publication status	Published - 8 Jun 2021

Keywords

Acute myocardial infarction
Anti-platelet therapy
Fibrinolysis
Myocardial ischemia
Novel anti-platelet medication
STEMI, NSTEMI

Access to Document

10.1007/978-3-030-71917-3_13

Cite this

@inbook{294fe708218b47b4a67fa8bd54ef20d8,

title = "Drugs in myocardial infarction",

abstract = "According to the {"}Fourth universal definition of myocardial infarction,{"} Acute Myocardial Infarction (AMI) is a {"}myocardial injury detected by abnormal cardiac biomarkers with clinical evidence of acute myocardial ischemia{"} [1]. The criteria include abnormal cardiac troponin (cTn) values with at least one value above the 99th percentile upper reference limit (URL), and at least one of the following:",

keywords = "Acute myocardial infarction, Anti-platelet therapy, Fibrinolysis, Myocardial ischemia, Novel anti-platelet medication, STEMI, NSTEMI",

author = "Margherita Tozzi and \{Di Piazza\}, Martina and Paolo Meani",

year = "2021",

month = jun,

day = "8",

doi = "10.1007/978-3-030-71917-3\_13",

language = "English",

isbn = "9783030719166",

pages = "115--124",

editor = "Giovanni Landoni and \{Baiardo Redaelli\}, Martina and Chiara Sartini and Alberto Zangrillo and Rinaldo Bellomo",

booktitle = "Reducing Mortality in Critically Ill Patients",

publisher = "Springer International Publishing",

address = "Switzerland",

edition = "2",

}

Drugs in myocardial infarction. / Tozzi, Margherita; Di Piazza, Martina; Meani, Paolo.
Reducing Mortality in Critically Ill Patients. ed. / Giovanni Landoni; Martina Baiardo Redaelli; Chiara Sartini; Alberto Zangrillo; Rinaldo Bellomo. 2. ed. Springer International Publishing, 2021. p. 115-124.

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic

TY - CHAP

T1 - Drugs in myocardial infarction

AU - Tozzi, Margherita

AU - Di Piazza, Martina

AU - Meani, Paolo

PY - 2021/6/8

Y1 - 2021/6/8

N2 - According to the "Fourth universal definition of myocardial infarction," Acute Myocardial Infarction (AMI) is a "myocardial injury detected by abnormal cardiac biomarkers with clinical evidence of acute myocardial ischemia" [1]. The criteria include abnormal cardiac troponin (cTn) values with at least one value above the 99th percentile upper reference limit (URL), and at least one of the following:

AB - According to the "Fourth universal definition of myocardial infarction," Acute Myocardial Infarction (AMI) is a "myocardial injury detected by abnormal cardiac biomarkers with clinical evidence of acute myocardial ischemia" [1]. The criteria include abnormal cardiac troponin (cTn) values with at least one value above the 99th percentile upper reference limit (URL), and at least one of the following:

KW - Acute myocardial infarction

KW - Anti-platelet therapy

KW - Fibrinolysis

KW - Myocardial ischemia

KW - Novel anti-platelet medication

KW - STEMI, NSTEMI

U2 - 10.1007/978-3-030-71917-3_13

DO - 10.1007/978-3-030-71917-3_13

M3 - Chapter

SN - 9783030719166

SP - 115

EP - 124

BT - Reducing Mortality in Critically Ill Patients

A2 - Landoni, Giovanni

A2 - Baiardo Redaelli, Martina

A2 - Sartini, Chiara

A2 - Zangrillo, Alberto

A2 - Bellomo, Rinaldo

PB - Springer International Publishing

ER -

Drugs in myocardial infarction

Abstract

Keywords

Access to Document

Fingerprint

Cite this